MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Cortical excitability in patients with Parkinson’s disease on levodopa carbidopa intestinal gel thereapy

S.D. Kim, S. Vucic, N. Mahant, M.C. Kiernan, V.S.C. Fung (Sydney, Australia)

Meeting: 2016 International Congress

Abstract Number: 1321

Keywords: Parkinsonism, Transcranial magnetic stimulation(TMS)

Session Information

Date: Wednesday, June 22, 2016

Session Title: Parkinson's disease: Neuroimaging and neurophysiology

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To assess whether there are changes in short interval intracortical inhibition (SICI) that reflect changes in motor function and plasma levodopa levels in patients with advanced Parkinson’s disease (PD).

Background: SICI has been investigated in both the OFF and ON-medication states in PD but the findings have been inconsistent. A number of studies have reported reduced SICI in the untreated or OFF-medication state particularly in those with more advanced disease, and further that the reduced SICI normalises with dopaminergic therapy, however other studies have failed to detect similar changes.

Methods: Six patients who have been established on levodopa carbidopa intestinal gel (LCIG) therapy for more than 12 months underwent assessment of their SICI, objective measure of bradykinesia and plasma levodopa levels. Studies were performed under two conditions, i.e. with the LCIG pump ON then OFF with serial measurements being made every 30 minutes. SICI was assessed using a threshold tracking paired-pulse TMS with the conditioning stimulus intensity set to 70% of resting motor threshold. Motor evoked potentials were recorded over the abductor pollicis brevis. Hand tapping rate was measured with a timed tapping task in which two electronic touch pads positioned 20 cm apart were tapped as fast as possible for 60 seconds.

Results: In the LCGI pump OFF condition, there was a rapid decline in plasma levodopa levels as expected but there was no significant reduction in hand tapping rate. SICI was comparable with controls in the LCGI pump ON condition, but became progressively reduced at subsequent time points in the OFF condition, being highly significant at 180 minutes (P<0.000). There was a statistically significant correlation between mean SICI and mean levodopa concentration (r = 0.900, P=0.037), but no correlation between mean hand tapping speed and either mean SICI or mean levodopa concentration.

Conclusions: The results from this study suggest that SICI is reduced in patients with severe PD and in addition SICI positively correlates with plasma levodopa levels. The findings suggest that SICI is influenced by the disease severity as well as plasma levodopa levels. Further, the findings raise the possibility that long term LCIG therapy may re-establish the long duration response given that hand tapping speed was maintained despite low plasma levodopa levels in advanced PD.

To cite this abstract in AMA style:

S.D. Kim, S. Vucic, N. Mahant, M.C. Kiernan, V.S.C. Fung. Cortical excitability in patients with Parkinson’s disease on levodopa carbidopa intestinal gel thereapy [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/cortical-excitability-in-patients-with-parkinsons-disease-on-levodopa-carbidopa-intestinal-gel-thereapy/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/cortical-excitability-in-patients-with-parkinsons-disease-on-levodopa-carbidopa-intestinal-gel-thereapy/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley